Society for Immunotherapy of Cancer (SITC) ^Non-Profit

The Society for Immunotherapy of Cancer (SITC) is the world’s leading member-driven organization specifically dedicated to improving cancer patient outcomes by advancing the science and application of cancer immunotherapy. Due to advances in cancer immunotherapy, including positive results from clinical trials testing new agents and combinations, emerging technologies for measuring different facets of immunity, and novel candidate biomarkers, the SITC Immune Biomarkers Oversight Committee has reconvened to review state of the art technologies, identify current hurdles to further success and to make recommendations to the field.